{
    "clinical_study": {
        "@rank": "82489", 
        "arm_group": [
            {
                "arm_group_label": "Early bisphosphonate use", 
                "arm_group_type": "Active Comparator", 
                "description": "Give risedronate (actonel) at 2 weeks after hemiarthroplasty for an osteoporotic femoral neck fracture. In addition, calcium and vitamin D supplementation will be given to all patients.\nRisedronate (35 mg) 1 tablet orally once a week"
            }, 
            {
                "arm_group_label": "Late bisphosphonate use", 
                "arm_group_type": "No Intervention", 
                "description": "Give only calcium and vitamin D supplementation during the first 3 months after the surgery.\nBisphosphonate, risedronate (Actonel), will be given at 3 months after surgery for an osteoporotic femoral neck fracture."
            }
        ], 
        "brief_summary": {
            "textblock": "Femoral neck fracture in the elderly is one indication for initiating osteoporosis\n      treatment. Bisphosphonates remain the first line therapy; however, many orthopaedic surgeons\n      concern regarding their effects on fracture healing process. Therefore, therapy is usually\n      delayed for a period of time. To the best of our knowledge, there is no scientific data to\n      support whether bisphosphonate treatment should be given immediately after the surgery or it\n      should be delayed."
        }, 
        "brief_title": "Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Osteoporotic Fractures", 
            "Femoral Neck Fracture"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Femoral Neck Fractures", 
                "Fractures, Bone", 
                "Osteoporotic Fractures"
            ]
        }, 
        "detailed_description": {
            "textblock": "Femoral neck fracture in the elderly is one indication for initiating osteoporosis\n      treatment. Bisphosphonates remain the first line therapy; however, many orthopaedic surgeons\n      concern regarding their effects on fracture healing process. Therefore, therapy is usually\n      delayed for a period of time. To the best of our knowledge, there is no scientific data to\n      support whether bisphosphonate treatment should be given immediately after the surgery or it\n      should be delayed.\n\n      This study aims to compare functional recovery between early- and late administration of\n      bisphosphonate in patients who received hemiarthroplasty following femoral neck fractures."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient diagnosed with femoral neck fracture and was treated with bipolar\n             hemiarthroplasty\n\n          -  Age more than 50 years old and bone mineral density (BMD) was in osteoporotic\n             (T-score less than -2.5) or osteopenic (T-score between -1.0 and -2.5) ranges\n\n        Exclusion Criteria:\n\n          -  Patients who were treated with bipolar hemiarthroplasty for more than 2 weeks\n\n          -  Patients with postoperative complications which affect the postoperative\n             rehabilitation program e.g. intraoperative cracking or fracture, postoperative\n             cardiac complication\n\n          -  Have contraindications for bisphosphonates use e.g. renal insufficiency (glomerular\n             filtration rate (GFR) < 30 ml/min), allergy to bisphosphonates, severe esophagitis,\n             gastroesophageal reflux disease etc.\n\n          -  Patients with conditions/disorders which have an affect on bone mineral density or\n             bone metabolism e.g. renal insufficiency, rheumatoid arthritis, Paget's disease,\n             renal osteodystrophy, hyperparathyroidism, glucocorticoids use etc.\n\n          -  History of bisphosphonates use within 12 months\n\n          -  Open fracture, multiple fracture or multiple trauma patients\n\n          -  Pathological fracture\n\n          -  Bilateral lower extremity fractures\n\n          -  The pre-injury functional status of the patients is non-ambulatory"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "86", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02148848", 
            "org_study_id": "229/2556(EC4)"
        }, 
        "intervention": {
            "arm_group_label": "Early bisphosphonate use", 
            "description": "Take risedronate 35 mg orally every week", 
            "intervention_name": "Risedronate", 
            "intervention_type": "Drug", 
            "other_name": "Actonel"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Risedronic acid", 
                "Diphosphonates"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Osteoporosis", 
            "Femoral neck fracture", 
            "hemiarthroplasty"
        ], 
        "lastchanged_date": "May 23, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bangkoknoi", 
                    "country": "Thailand", 
                    "state": "Bangkok", 
                    "zip": "10700"
                }, 
                "name": "Siriraj Hospital"
            }, 
            "investigator": {
                "last_name": "Aasis Unnanantana, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Comparative Study of Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty in Patients With Osteoporotic Femoral Neck Fractures", 
        "overall_contact": {
            "email": "uaasis@gmail.com", 
            "last_name": "Aasis Unanantana, M.D.", 
            "phone": "(66)24197968"
        }, 
        "overall_contact_backup": {
            "email": "p_you_n@hotmail.com", 
            "last_name": "Panai Laohaprasitiporn, M.D.", 
            "phone": "(66)24197968"
        }, 
        "overall_official": {
            "affiliation": "Siriraj Hospital, Mahidol University", 
            "last_name": "Aasis Unnanuntana, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Thailand: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "de Morton Mobility Index", 
            "safety_issue": "No", 
            "time_frame": "3 months after surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02148848"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Barthel index", 
                "safety_issue": "No", 
                "time_frame": "3 months after surgery"
            }, 
            {
                "measure": "Visual analog scale score", 
                "safety_issue": "No", 
                "time_frame": "3 months after surgery"
            }, 
            {
                "measure": "Two minutes walking test", 
                "safety_issue": "No", 
                "time_frame": "3 months after surgery"
            }, 
            {
                "measure": "Timed get up and go test", 
                "safety_issue": "No", 
                "time_frame": "3 months after surgery"
            }, 
            {
                "measure": "EuroQoL-5D (EQ-5D)", 
                "safety_issue": "No", 
                "time_frame": "3 months after surgery"
            }
        ], 
        "source": "Mahidol University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mahidol University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}